Search results
Results from the WOW.Com Content Network
Nature Biotechnology is a monthly peer-reviewed scientific journal published by Nature Portfolio. The editor-in-chief is Barbara Cheifet who heads an in-house team of editors. [ 1 ] The focus of the journal is biotechnology including research results and the commercial business sector of this field.
Nature ' s impact factor, a measure of how many citations a journal generates in other works, was 42.778 in 2019 (as measured by Thomson ISI). [1] [35] [36] However, as with many journals, most papers receive far fewer citations than the impact factor would indicate. [37] Nature's journal impact factor carries a long tail. [38]
The Nature Partner Journals series, abbreviated npj, is a series of online-only, open access, journals. It was launched in April 2014 with three journals: npj Primary Care Respiratory Medicine , npj Biofilms and Microbiomes , and npj Schizophrenia .
Microbial biotechnology has been proposed for the rapidly emerging area of biotechnology applications in space and microgravity (space bioeconomy) [41] Dark biotechnology is the color associated with bioterrorism or biological weapons and biowarfare which uses microorganisms, and toxins to cause diseases and death in humans, livestock and crops.
Voigt is the Daniel I.C. Wang Professor of Advanced Biotechnology in the Department of Biological Engineering at Massachusetts Institute of Technology (MIT). He works in the developing field of synthetic biology. He is the co-director of the Synthetic Biology Center [3] at MIT and the co-founder of the MIT-Broad Foundry. [4] [5]
In 2016, Marks was awarded the Overton Prize by the International Society for Computational Biology. [16]In 2018, Marks was awarded the Ben Barres Early Career Award by the Chan Zuckerberg Initiative as part of the Neurodegeneration Challenge Network.
Discover the best free online games at AOL.com - Play board, card, casino, puzzle and many more online games while chatting with others in real-time.
The American Society of Human Genetics had declared in 2017 that the basic research on in vitro human genome editing on embryos and gametes should be promoted but that "At this time, given the nature and number of unanswered scientific, ethical, and policy questions, it is inappropriate to perform germline gene editing that culminates in human ...